ArticlePublic health challenges2023
Will Cape Verde attain COVID-19 herd immunity? Progress, Challenges, and Recommendations.
Article in Public health challenges, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Will Cape Verde attain COVID-19 herd immunity? Progress, Challenges, and Recommendations.Public health challenges · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The COVID-19 pandemic has exposed the vulnerabilities of Cape Verde's healthcare system, prompting a swift and effective response. This article examines Cape Verde's comprehensive approach to the pandemic, focusing on epidemiology, the healthcare system, and the vaccination campaign. Recognizing the critical role of COVID-19 vaccination in global efforts, Cape Verde has implemented strategic measures to achieve herd immunity. Although the country has achieved relatively high vaccination coverage in Africa, it still falls short of the necessary threshold. Challenges, including vaccine hesitancy, viral mutations, and supply chain insecurities, must be addressed. Sustained efforts, involving community participation and improved vaccine availability, are crucial. Furthermore, a robust pharmacovigilance system is essential for ensuring vaccination safety and enhancing health outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.